
Momespray50 mcg
Navana Pharmaceuticals Ltd.
Mometasone Furoate is a synthetic corticosteroid used topically, intranasally, and by oral inhalation depending on the formulation.
Mometasone Furoate is a synthetic corticosteroid used topically, intranasally, and by oral inhalation depending on the formulation. Its approved and guideline-supported uses include:
Mometasone Furoate inhaled and intranasal forms are for maintenance/prophylactic use only and are not intended to relieve acute bronchospasm or acute nasal symptoms.
| Population | Dose |
|---|---|
| Adults and children ≥2 years | Apply a thin film to the affected skin area once daily; discontinue when control is achieved |
| Indication | Population | Dose |
|---|---|---|
| Allergic rhinitis | Adults and children ≥12 years | 2 sprays in each nostril once daily (200 mcg/day total) |
| Allergic rhinitis (OTC products) | Children 2-11 years | 1 spray in each nostril once daily under adult supervision |
| Chronic rhinosinusitis with nasal polyps | Adults ≥18 years | 2 sprays in each nostril twice daily (up to 400 mcg/day); some patients may respond to once-daily dosing |
| Population | Prior therapy | Starting dose |
|---|---|---|
| Adults and adolescents ≥12 years | Previously on bronchodilators alone or inhaled corticosteroids | 220 mcg once daily in the evening (up to 220 mcg twice daily in more severe disease) |
| Adults and adolescents ≥12 years | Previously on oral corticosteroids | 220 mcg twice daily |
| Children 4-11 years | Allergic asthma | 110 mcg once daily in the evening |
Rinse the mouth after each inhaled dose without swallowing to reduce the risk of oral candidiasis. Shake nasal spray before use; prime the pump before first use or after periods of non-use per product labeling. Mometasone Furoate inhaler and nasal spray are not intended for relief of acute symptoms; a fast-acting bronchodilator should be used for acute asthma symptoms, not the inhaled form of Mometasone Furoate.
Systemic corticosteroid effects (e.g., adrenal suppression, Cushingoid features) are rare with Mometasone Furoate at recommended doses but may occur with excessive or prolonged use, especially in combination with other corticosteroid sources.
Mometasone Furoate is contraindicated in patients with known hypersensitivity to mometasone furoate or to any component of the specific formulation.
The inhaled form is contraindicated for the primary treatment of status asthmaticus or other acute episodes of asthma requiring intensive measures, as it is not a bronchodilator and has no role in relieving acute bronchospasm.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.